AAV-mediated expression of Bcl-xL or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning

Neuroscience Letters
A P Kells, Bronwen Connor

Abstract

Apoptotic mechanisms have been proposed to contribute to the selective loss of medium spiny striatal projection neurons in Huntington's disease (HD). This raises the question as to whether enhancing the expression of anti-apoptotic factors in vulnerable striatal projection neurons can reduce their susceptibility to neurotoxic processes occurring in the HD brain. In this study AAV 1/2 vectors encoding either the anti-apoptotic factor Bcl-xL or XIAP were used to transduce striatal neurons prior to an intrastriatal injection of the excitotoxic glutamate analogue quinolinic acid (QA). AAV 1/2 vector treated rats were observed in behavioural tests undertaken to assess whether anti-apoptotic factor expression provided amelioration of motor function impairment following unilateral QA-induced striatal lesioning. AAV-XIAP treated rats displayed complete amelioration of an ipsilateral forelimb use bias relative to control animals. However, neither AAV-XIAP nor AAV-Bcl-xL treated rats demonstrated an improvement in sensorimotor neglect compared to control animals. Furthermore, we did not observe a significant reduction of QA-induced pathology in assessed neuronal populations of the basal ganglia. These results indicate that sole enhanceme...Continue Reading

References

Jun 1, 1995·Experimental Neurology·L B ThomasD A Steindler
Dec 18, 2001·Journal of Neuroscience Research·C CepedaM S Levine
Jan 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brian K KasparDaniel A Peterson
Jul 4, 2002·Neuromolecular Medicine·Tamara KiechleRobert J Ferrante
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Miriam A Hickey, Marie Françoise Chesselet
Oct 4, 2003·Cytogenetic and Genome Research·A SawaB-I Bae
Oct 14, 2003·Experimental Neurology·Evelise N MacielRoger F Castilho
Mar 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cristina RichichiAnnamaria Vezzani
May 4, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adrian P KellsBronwen Connor
Dec 9, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Liang-Fong WongNicholas D Mazarakis
Jan 26, 2005·Acta Neuropathologica·José C VisBerry Kremer
Aug 24, 2005·Muscle & Nerve·Mary E Garrity-MosesNicholas M Boulis
Dec 13, 2005·Clinical Science·Olivia J HandleyAnne E Rosser
Dec 21, 2006·Journal of Neuroscience Methods·Adrian P KellsBronwen Connor

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.